Table 1.
Clinical characteristics at recruitment of treatment and control groups.
| Enalapril group | Control group | P | |
|---|---|---|---|
| Number of patients (n) | 21 | 21 | n.s. |
| Sex (M/F) | 11/10 | 12/9 | n.s. |
| Age (years) | 67 ± 11 | 65 ± 9 | n.s. |
| BMI (Kg/m2) | 26.4 ± 1.2 | 26.6 ± 1.1 | n.s. |
| GFR at initiation of HD (mL/min/1.73 m2) | 8.1 ± 2.1 | 8.0 ± 2.0 | n.s. |
| Loop diuretics | 17 | 16 | n.s. |
| C-reactive protein (mg/dL) | 0.92 ± 0.9 | 1.0 ± 0.96 | n.s. |
|
| |||
| Primary kidney disease | |||
|
| |||
| Diabetes | 6 | 5 | |
| Glomerulonephritis | 5 | 5 | |
| Hypertension | 3 | 2 | |
| PKD | 2 | 1 | |
| Unknown/various | 5 | 8 | |
Values are expresses as mean ± SD.